David A. Zidar MD
Adult Congenital Heart Disease, Interventional Cardiology
Assistant Professor, Medicine, Case Western Reserve University School of Medicine
Join to view full profile
24701 Euclid AveEuclid, OH 44117
Phone+1 216-444-2000
Fax+1 216-844-8954
Dr. Zidar is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Duke University HospitalFellowship, Interventional Cardiology, 2009 - 2010- Duke University HospitalFellowship, Cardiovascular Disease, 2006 - 2009
Johns Hopkins UniversityResidency, Internal Medicine, 1998 - 2001
Duke University School of MedicineClass of 1998
Certifications & Licensure
OH State Medical License 2010 - 2027
MI State Medical License 2023 - 2026
NC State Medical License 2001 - 2012
American Board of Internal Medicine Cardiovascular Disease- American Board of Internal Medicine Interventional Cardiology
National Board of Physicians and Surgeons Cardiovascular Disease- National Board of Physicians and Surgeons Interventional Cardiology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts TouchWorks EHR, Allscripts, 2014, 2016
Clinical Trials
Publications & Presentations
PubMed
- Differences in all-cause mortality by sex in obstructive and restrictive lung diseases.Carli J Lehr, Jacob Mitchell, Elizabeth N Dewey, David A Zidar, Vickram Tejwani
Chronic Respiratory Disease. 2026-08-22 - Cerebrovascular Accident Risk in Survivors of Head and Neck Cancer: JACC CardioOncology State-of-the-Art Review.Courtney Pisano, Jenica Upshaw, Benjamin Colvard, David Zidar, Ryan Hughes
JACC. Cardiooncology. 2026-08-01 - Long-Term Outcomes of Glucagon-Like Peptide-1 Receptor Agonists in Patients With Peripheral Artery Disease and Type 2 Diabetes.Akiva Rosenzveig, Leben Tefera, Ankit Agrawal, Judah Rajendran, Faysal Massad
Journal of the American Heart Association. 2026-07-01
Press Mentions
Study Underlines Importance of COVID-19 Booster for Cancer PatientsJuly 17th, 2025- Cancer: COVID-19 Boosters Prevent HospitalizationsJuly 17th, 2025
- Cleveland Research Centers Receive $2.6m & Participate in NCI’s ‘SeroNet’ Study of Human Immune Responses to COVID-19November 18th, 2020
Grant Support
- Pre-exposure Immunologic Health and Linkages to SARS-COV2 Serologic Responses, Endothelial Cell Resilience, and Cardiovascular Complications: Defining the mechanistic basis of high risk endotypes.CASE WESTERN RESERVE UNIVERSITY2020–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
